Anzeige
Mehr »
Login
Donnerstag, 04.03.2021 Börsentäglich über 12.000 News von 657 internationalen Medien
Übernahme-News! Relay Medical im Fokus der Anleger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12EZ0 ISIN: US31572Q8087 Ticker-Symbol: 1FG 
Tradegate
03.03.21
21:48 Uhr
28,820 Euro
-2,670
-8,48 %
1-Jahres-Chart
FIBROGEN INC Chart 1 Jahr
5-Tage-Chart
FIBROGEN INC 5-Tage-Chart
RealtimeGeldBriefZeit
28,22028,82003.03.
28,30028,64003.03.

Aktuelle News zur FIBROGEN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiFDA slaps FibroGen, AstraZeneca with last-minute roxadustat AdCom, cuing another delay for anemia drug11
FIBROGEN Aktie jetzt für 0€ handeln
DiFathoming The FDA Decision On FibroGen9
DiFibroGen Tumbles on Earnings Miss, FDA Meeting Notice16
DiNanoViricides, CHF Solutions leads healthcare gainers; FibroGen, Neuronetics among major losers15
DiFibroGen shares plummet 24% as FDA meeting, Jefferies downgrade weigh28
DiThe Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data37
DiFibroGen shares skid lower as a surprise adcomm raises risks on roxa OK17
DiFDA to review AstraZeneca and FibroGen's Roxadustat28
DiFDA to hold AdCom meet to review FibroGen, AstraZeneca's kidney drug18
DiAstraZeneca, FibroGen say FDA to review anaemia of chronic kidney disease drug application19
DiAstraZeneca, FibroGen: FDA To Convene Committee Meeting To Review Roxadustat In Anaemia Of CKD241LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L, AZN) announced Tuesday that the US Food and Drug Administration or FDA informed FibroGen, Inc. that it will convene a meeting of the Cardiovascular...
► Artikel lesen
DiFibroGen's (FGEN) CEO Enrique Conterno on Q4 2020 Results - Earnings Call Transcript19
MoFibroGen, Inc: FibroGen Reports Fourth Quarter and Full Year 2020 Financial Results11
MoFibroGen, Inc: FibroGen Provides Regulatory Update on Roxadustat5
SoFibroGen Q4 2020 Earnings Preview3
18.02.FibroGen, Inc: FibroGen to Report Fourth Quarter and Full Year 2020 Financial Results8
12.02.FibroGen, Inc: FibroGen to Present at Upcoming Investor Conferences5
27.01.FibroGen announces supply deal for roxadustat with Astellas19
24.12.20FibroGen: Roxadustat's U.S. Approval, 2020 China Sales, And Outsized Growth23
22.12.20Dosing underway in FibroGen's late-stage pamrevlumab study in chronic lung disease6
Seite:  Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1